Anthony W Castleberry1, Muath Bishawi2, Mathias Worni3, Loretta Erhunmwunsee2, Paul J Speicher2, Asishana A Osho4, Laurie D Snyder5, Matthew G Hartwig2. 1. Department of Surgery, Division of Cardiothoracic Surgery, Duke University Medical Center, Durham, North Carolina. Electronic address: anthony.castleberry@duke.edu. 2. Department of Surgery, Division of Cardiothoracic Surgery, Duke University Medical Center, Durham, North Carolina. 3. Department of Surgery, Division of Cardiothoracic Surgery, Duke University Medical Center, Durham, North Carolina; Department of Visceral Surgery and Medicine, Inselspital, University of Berne, Berne, Switzerland. 4. Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts. 5. Division of Pulmonary and Critical Care, Duke University Medical Center, Durham, North Carolina.
Abstract
BACKGROUND: Our objective was to identify potential avenues for resource allocation and patient advocacy to improve outcomes by evaluating the association between recipient sociodemographic and patient characteristics and medication nonadherence after lung transplantation. METHODS: States US adult, lung-only transplantations per the United Network for Organ Sharing database were analyzed from October 1996 through December 2006, based on the period during which nonadherence information was recorded. Generalized linear models were used to determine the association of demographic, disease, and transplantation center characteristics with early nonadherence (defined as within the first year after transplantation) as well as late nonadherence (years 2 to 4 after transplantation). Outcomes comparing adherent and nonadherent patients were also evaluated. RESULTS: Patients (n = 7,284) were included for analysis. Early and late nonadherence rates were 3.1% and 10.6%, respectively. Factors associated with early nonadherence were Medicaid insurance compared with private insurance (adjusted odds ratio [AOR] 2.45, 95% confidence interval [CI]: 1.16 to 5.15), and black race (AOR 2.38, 95% CI: 1.08 to 5.25). Medicaid insurance and black race were also associated with late nonadherence (AOR 2.38, 95% CI: 1.51 to 3.73 and OR 1.73, 95% CI: 1.04 to 2.89, respectively), as were age 18 to 20 years (AOR 3.41, 95% CI: 1.29 to 8.99) and grade school or lower education (AOR 1.88, 95% CI: 1.05 to 3.35). Early and late nonadherence were both associated with significantly shorter unadjusted survival (p < 0.001). CONCLUSIONS: Identifying patients at risk of nonadherence may enable resource allocation and patient advocacy to improve outcomes.
BACKGROUND: Our objective was to identify potential avenues for resource allocation and patient advocacy to improve outcomes by evaluating the association between recipient sociodemographic and patient characteristics and medication nonadherence after lung transplantation. METHODS: States US adult, lung-only transplantations per the United Network for Organ Sharing database were analyzed from October 1996 through December 2006, based on the period during which nonadherence information was recorded. Generalized linear models were used to determine the association of demographic, disease, and transplantation center characteristics with early nonadherence (defined as within the first year after transplantation) as well as late nonadherence (years 2 to 4 after transplantation). Outcomes comparing adherent and nonadherent patients were also evaluated. RESULTS:Patients (n = 7,284) were included for analysis. Early and late nonadherence rates were 3.1% and 10.6%, respectively. Factors associated with early nonadherence were Medicaid insurance compared with private insurance (adjusted odds ratio [AOR] 2.45, 95% confidence interval [CI]: 1.16 to 5.15), and black race (AOR 2.38, 95% CI: 1.08 to 5.25). Medicaid insurance and black race were also associated with late nonadherence (AOR 2.38, 95% CI: 1.51 to 3.73 and OR 1.73, 95% CI: 1.04 to 2.89, respectively), as were age 18 to 20 years (AOR 3.41, 95% CI: 1.29 to 8.99) and grade school or lower education (AOR 1.88, 95% CI: 1.05 to 3.35). Early and late nonadherence were both associated with significantly shorter unadjusted survival (p < 0.001). CONCLUSIONS: Identifying patients at risk of nonadherence may enable resource allocation and patient advocacy to improve outcomes.
Authors: Jason D Christie; Leah B Edwards; Anna Y Kucheryavaya; Christian Benden; Fabienne Dobbels; Richard Kirk; Axel O Rahmel; Josef Stehlik; Marshall I Hertz Journal: J Heart Lung Transplant Date: 2011-10 Impact factor: 10.247
Authors: Alexandre S Quadros; Dulce I Welter; Fernanda O Camozzatto; Aurea Chaves; Rajendra H Mehta; Carlos A Gottschall; Renato D Lopes Journal: Am J Cardiol Date: 2010-12-22 Impact factor: 2.778
Authors: Mary Amanda Dew; Andrea F Dimartini; Annette De Vito Dabbs; Rachelle Zomak; Sabina De Geest; Fabienne Dobbels; Larissa Myaskovsky; Galen E Switzer; Mark Unruh; Jennifer L Steel; Robert L Kormos; Kenneth R McCurry Journal: Transplantation Date: 2008-01-27 Impact factor: 4.939
Authors: Otto H Bosma; Karin M Vermeulen; Erik A Verschuuren; Michiel E Erasmus; Wim van der Bij Journal: J Heart Lung Transplant Date: 2011-07-02 Impact factor: 10.247
Authors: G Germani; S Lazzaro; F Gnoato; M Senzolo; V Borella; G Rupolo; U Cillo; P Rigotti; G Feltrin; M Loy; A Martin; G C Sturniolo; P Burra Journal: Transplant Proc Date: 2011 Jan-Feb Impact factor: 1.066
Authors: Keith M Wille; Kathy F Harrington; Joao A deAndrade; Sonia Vishin; Robert A Oster; Richard A Kaslow Journal: J Heart Lung Transplant Date: 2013-04-09 Impact factor: 10.247
Authors: Jeffrey J Ellis; Steven R Erickson; James G Stevenson; Steven J Bernstein; Renee A Stiles; A Mark Fendrick Journal: J Gen Intern Med Date: 2004-06 Impact factor: 5.128
Authors: Emily M Geramita; Annette J DeVito Dabbs; Andrea F DiMartini; Joseph M Pilewski; Galen E Switzer; Donna M Posluszny; Larissa Myaskovsky; Mary Amanda Dew Journal: Transplantation Date: 2020-03 Impact factor: 5.385
Authors: Patrick J Smith; Gregory L Stonerock; Krista K Ingle; Caroline K Saulino; Benson Hoffman; Brian Wasserman; James A Blumenthal; Scott M Palmer; Jacob A Klapper; Matthew G Hartwig; Valentine R Esposito; Laurie D Snyder Journal: Transplant Direct Date: 2018-03-19
Authors: Anna Bertram; Jan Fuge; Hendrik Suhling; Igor Tudorache; Axel Haverich; Tobias Welte; Jens Gottlieb Journal: PLoS One Date: 2019-12-17 Impact factor: 3.240
Authors: Agnieszka Kisielska; Daria Schneider-Matyka; Kamila Rachubińska; Przemysław Ustanowski; Anita Rybicka; Elżbieta Grochans Journal: Int J Environ Res Public Health Date: 2022-04-01 Impact factor: 3.390